IMULDOSA

Golden State Medical Supply, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 21, 2025
Approval ID: 37cd1317-5903-cd49-e063-6394a90addc5
Products: 3 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

IMULDOSA (ustekinumab-srlf) injection. These highlights do not include all the information needed to use IMULDOSA safely and effectively. See full prescribing information for IMULDOSA. IMULDOSA (ustekinumab-srlf) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2024 IMULDOSA (ustekinumab-srlf) is biosimilar* to STELARA (ustekinumab)

Quick Stats

Total Products3

Labelers1

Label Sections38

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.